Wellcome Expert Discusses Importance Of Investing In Antibiotic Development

Wellcome: Race for new antibiotics: future success is hanging by a thread
Tim Jinks, head of the Drug-resistant Infections Program at Wellcome, discusses the importance of stepping up investments in antibiotic development, highlighting his recent piece published in The Times and writing, “The world desperately needs new antibiotics — they are the foundation of modern medicine. … Industry and governments must recognize their shared interest in getting new antibiotics to the patients who need them the most” (1/28).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.